Bortezomib for injection is available in 3.5 mg strength, packaged in a single-dose vial.
PISCATAWAY, N.J. –Camber Pharmaceuticals is excited to announce the addition of bortezomib for injection.
Bortezomib for injection is a proteasome inhibitor indicated for:
• treatment of adult patients with multiple myeloma
• treatment of adult patients with mantle cell lymphoma
Bortezomib for injection is available in 3.5 mg strength, packaged in a single-dose vial.
The NACDS Foundation's Faculty Scholars Program supports pharmacy professors in advancing impactful research.
Wellness Day offers families a chance to engage with Walmart pharmacists on various health topics.
GoodRx for Pets leverages new integrated e-commerce capabilities to create a seamless user experience for accessing essential pet medications and information.
Dr. Affeldt is poised to lead HOSP toward continued growth and influence in the healthcare landscape.
The NACDS Foundation's Faculty Scholars Program supports pharmacy professors in advancing impactful research.
“The health of pregnant women and their babies is paramount, and it is critical that public discourse surrounding prenatal vitamins is grounded in robust, accurate science.”
Shortly following expansion in Walmart and Sprouts, the female-founded startup is now available at Target.
Mobile apps are becoming essential for retail operations, driving efficiency and enhancing customer experiences.
